Sex-Related Differences in Heart Failure Development in Patients After First Myocardial Infarction: The Role of Galectin-3

Sex-Related Differences in Heart Failure Development in Patients After First Myocardial Infarction: The Role of Galectin-3

<b>Backgrounds:</b> Galectin-3 (gal-3) is upregulated in remodeling, and failing myocardium and gal-3 levels are increased in hypertrophy, fibrosis and inflammation. The aim of this study was to investigate the potential role of sex-related differences in the following: risk factors, lef...

Full description

Saved in:

Bibliographic Details
Main Authors:	Milica Dekleva, Tamara Djuric, Ana Djordjevic, Ivan Soldatovic, Aleksandra Stankovic, Jelena Suzic Lazic, Maja Zivkovic
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Biomedicines
Subjects:	heart failure myocardial infarction galectin-3 <i>LGALS-3</i> mRNA gal-3 ELISA
Online Access:	https://www.mdpi.com/2227-9059/12/12/2661
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Altered glycosylation of EVs in cancers: galectin-3-binding protein (LGALS3BP)
by: Jie-Yi Koh Kok, et al.
Published: (2025-07-01)

Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01)

Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)

Obesity-driven changes in breast tissue exhibit a pro-angiogenic extracellular matrix signature
by: Ellen E. Bamberg, et al.
Published: (2024-12-01)

The <i>LGALS1</i> gene polymorphism is not associated with galectin-1 levels in tumor tissue and blood of colon cancer patients
by: Olga I. Urazova, et al.
Published: (2024-09-01)

Galectins: a potential pharmacological target
by: V. A. Serebryakova, et al.
Published: (2024-10-01)

Galectin-1 and Galectin-3 expression in colon cancer and its correlation with tumor invasion, differentiation, and metastatic spread
by: Yu. V. Kolobovnikova, et al.
Published: (2021-12-01)

Galectin-3: Integrator of Signaling via Hexosamine Flux
by: Mana Mohan Mukherjee, et al.
Published: (2025-07-01)

Diagnostic usefulness of Galectin-3 in thyroid gland nodular lesions
by: D. I. Kebalo, et al.
Published: (2015-12-01)

Predictive value of circulating galectin-3 in patients with multiple myeloma in remission
by: B. B. Samura
Published: (2015-08-01)

The Role of Cystatin C and Galectin-3 in Cardiorenal Syndrome
by: Nazar Ahemd Naji, et al.
Published: (2023-02-01)

Galectin-3 and its relationship with the state of coronary arteries in patients with acute myocardial infarction and concomitant obesity
by: O. S. Yermak, et al.
Published: (2019-02-01)

A systematic review and meta-analysis of the association between galectin-3 levels and clinical outcomes in COVID-19 patients
by: Kacper DZIEDZIC, et al.
Published: (2023-12-01)

Galectin-3 in heart recipients
by: A. A. Ulybysheva, et al.
Published: (2019-07-01)

Plasma levels of soluble PD-1, TIM-3, LAG-3 and galectin-3 and the degree of liver fibrosis in CHC and the impact of successful antiviral treatment on their levels
by: Sylwia Osuch, et al.
Published: (2025-05-01)

Galectin-9 treatment is cytotoxic for B cell lymphoma by disrupting autophagy
by: Lisanne Koll, et al.
Published: (2025-06-01)

Plasma galectin-3 is associated with decreased glomerular filtration rate in chronic HIV
by: Diana L. Vares-Lum, et al.
Published: (2023-12-01)

Galectin-3 in the blood serum of patients with bone tumors
by: N. E. Kushlinskii, et al.
Published: (2023-07-01)

Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Galectin-3 in heart transplant rejection and fibrosis
by: O. P. Shevchenko, et al.
Published: (2019-10-01)

Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Galectin-3 in solid organ recipients: role in graft pathology and prospects for use
by: D. A. Velikiy, et al.
Published: (2023-07-01)

A correlational study of plasma galectin-3 as a potential predictive marker of postoperative delirium in patients with acute aortic dissection
by: Fei Jiang, et al.
Published: (2025-05-01)

PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 LEVEL ASSESSMENT IN METABOLIC SYNDROME PATIENTS WITH HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2017-12-01)

Value of circulating galectin-3 for prognosis of cardiovascular events in patients with chronic lymphocytic leukemia in remission
by: B. B. Samura, et al.
Published: (2014-12-01)

Elevated expression of galectin-3 in excessive scars: A pilot study
by: Victor Freire Salomão Ferreira, et al.
Published: (2024-10-01)

Elevated levels of serum PKM2, Gal-3 and CitH3 could predict pulmonary infection complicated by mechanical ventilation
by: HUANG Hangdong, LI Danyu, ZHU Xiaofeng
Published: (2025-01-01)

Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
by: Xierenguli Alimu, et al.
Published: (2023-05-01)

Functional Verification and Prognostic Value of Neutrophil Extracellular Trap-Related Genes in Pancreatic Cancer Progression
by: Jiaxin Xu, et al.
Published: (2025-06-01)

Screening differentially expressed proteins to distinguish thymoma (B1 and B3) from thymic cysts based on tandem mass tag (TMT) technology
by: Jingwei Shi, et al.
Published: (2024-10-01)

GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01)

Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma
by: Shadi Chamseddine, et al.
Published: (2024-11-01)

Glyceraldehyde 3-Phosphate Dehydrogenase and Galectin from <i>Dirofilaria immitis</i> Excretory/Secretory Antigens Activate Proangiogenic Pathway in In Vitro Vascular Endothelial Cell Model
by: Manuel Collado-Cuadrado, et al.
Published: (2025-03-01)

Galectin-9: diverse roles in skin disease
by: Lin Wang, et al.
Published: (2025-07-01)

Study of the Elevation of Galectin-3 Level in Plasma Patients with Inflammatory Bowel Disease in Babylon Province
by: Arkan Khanjar Nasrullah, et al.
Published: (2025-01-01)

Serum matrix metalloproteinase-2,9 activity, galectin-3 and systemic inflammation in patients with postinfarction heart failure with preserved ejection fraction.
by: O. Kuryata, et al.
Published: (2018-04-01)

Galectin-3 in recipients with kidney graft dysfunction: analysis of predictive significance
by: D. A. Velikiy, et al.
Published: (2024-09-01)

Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
by: Anne Rombaut, et al.
Published: (2024-11-01)

Leveraging AI to optimize galectin-3 inhibitors for Alzheimer’s disease: How to move forwards
by: Huiyong Zhang, et al.
Published: (2025-08-01)

Serum sICAM-1 and Galectin-3 Levels in Diabetic Patients with COVID-19
by: Busra Karahan, et al.
Published: (2025-07-01)